These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 15314975

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells.
    El-Rayes BF, Grignon R, Aslam N, Aranha O, Sarkar FH.
    Int J Oncol; 2002 Jul; 21(1):207-11. PubMed ID: 12063570
    [Abstract] [Full Text] [Related]

  • 24. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
    Taguchi T, Kato Y, Baba Y, Nishimura G, Tanigaki Y, Horiuchi C, Mochimatsu I, Tsukuda M.
    Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078
    [Abstract] [Full Text] [Related]

  • 25. The preliminary estimation of bcl-2, bcl-X(L) and p53 genes expression in locally advanced non-small cell lung cancer.
    Karczmarek-Borowska B, Filip A, Zdunek M, Korobowicz E, Wojcierowski J, Korszeń-Pilecka I, Furmanik F.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Feb; 58(1):124-31. PubMed ID: 15314971
    [Abstract] [Full Text] [Related]

  • 26. Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.
    Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M, Dmitrovsky E.
    Cancer Res; 1995 Nov 01; 55(21):5038-42. PubMed ID: 7585548
    [Abstract] [Full Text] [Related]

  • 27. Cytotoxic effects of camptothecin and cisplatin combined with tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in a model of primary culture of non-small cell lung cancer.
    Frese S, Schüller A, Frese-Schaper M, Gugger M, Schmid RA.
    Anticancer Res; 2009 Aug 01; 29(8):2905-11. PubMed ID: 19661294
    [Abstract] [Full Text] [Related]

  • 28. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial.
    Burkes RL, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson FG, Jones D, Farooq S, McGlaughlin J, Ginsberg RJ.
    Lung Cancer; 2005 Jan 01; 47(1):103-9. PubMed ID: 15603860
    [Abstract] [Full Text] [Related]

  • 29. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
    Kalomenidis I, Orphanidou D, Papamichalis G, Vassilakopoulos T, Scorilas A, Rasidakis A, Papastamatiou H, Jordanoglou J, Roussos C.
    Lung; 2001 Jan 01; 179(5):265-78. PubMed ID: 11976895
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review.
    Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, Albelda SM.
    Clin Cancer Res; 2005 Jun 01; 11(11):3974-86. PubMed ID: 15930332
    [Abstract] [Full Text] [Related]

  • 32. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP.
    Ann Thorac Surg; 2009 Sep 01; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [Abstract] [Full Text] [Related]

  • 33. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G, Ruby E, Góhér I, Gábor G, Mohos A, Lengyel M.
    Orv Hetil; 2005 Jul 03; 146(27):1433-8. PubMed ID: 16089103
    [Abstract] [Full Text] [Related]

  • 34. Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy.
    Hubaux R, Vandermeers F, Crisanti MC, Kapoor V, Burny A, Mascaux C, Albelda SM, Willems L.
    Eur J Cancer; 2010 Jun 03; 46(9):1724-34. PubMed ID: 20451370
    [Abstract] [Full Text] [Related]

  • 35. Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells.
    Wang L, Chanvorachote P, Toledo D, Stehlik C, Mercer RR, Castranova V, Rojanasakul Y.
    Mol Pharmacol; 2008 Jan 03; 73(1):119-27. PubMed ID: 17911532
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Distribution of Bcl-2 gene expression and its prognostic value in non-small cell lung cancer.
    Yilmaz A, Savaş I, Dizbay Sak S, Güngör A, Kaya A, Serinsöz E, Savaş B.
    Tuberk Toraks; 2005 Jan 03; 53(4):323-9. PubMed ID: 16456730
    [Abstract] [Full Text] [Related]

  • 38. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients.
    Boulay JL, Perruchoud AP, Reuter J, Bolliger C, Herrmann R, Rochlitz C.
    Cancer Gene Ther; 2000 Sep 03; 7(9):1215-9. PubMed ID: 11023193
    [Abstract] [Full Text] [Related]

  • 39. P53 immunostaining predicts chemosensitivity in non-small cell lung cancer: A preliminary report.
    Kawasaki M, Nakanishi Y, Yatsunami J, Takayama K, Ochiai S, Xinhai P, Kuwano K, Hara N.
    Cancer J Sci Am; 1996 Sep 03; 2(4):217-20. PubMed ID: 9166535
    [Abstract] [Full Text] [Related]

  • 40. Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus.
    Heeren PA, Kloppenberg FW, Hollema H, Mulder NH, Nap RE, Plukker JT.
    Anticancer Res; 2004 Sep 03; 24(4):2579-83. PubMed ID: 15330218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.